References
1 Ferraro V, Carraro S, Bozzetto S, et al. Exhaled biomarkers in childhood asthma: old and new approaches[J]. Asthma Res Pract, 2018, 4: 9. PMID: 30094051. PMCID: PMC6081883. DOI: 10.1186/s40733-018-0045-6.
2 Xu J, Yin Y, Zhang H, et al. Paediatric asthma control under a community management model in China: a protocol for a prospective multicentre cohort study[J]. BMJ Open, 2017, 7(8): e015741. PMID: 28780547. PMCID: PMC5724237. DOI: 10.1136/bmjopen-2016-015741.
3 Ferraro VA, Zanconato S, Baraldi E, et al. Nitric oxide and biological mediators in pediatric chronic rhinosinusitis and asthma[J]. J Clin Med, 2019, 8(11): 1783. PMID: 31731479. PMCID: PMC6912805. DOI: 10.3390/jcm8111783.
4 Galiniak S, Biesiadecki M, Aebisher D, et al. Nasal nitric oxide in upper airways in children with asthma and allergic rhinitis[J]. Adv Med Sci, 2020, 65(1): 127-133. PMID: 31927424. DOI: 10.1016/j.advms.2019.11.005.
5 Wen YS, Lin CY, Yang KD, et al. Nasal nitric oxide is a useful biomarker for acute unilateral maxillary sinusitis in pediatric allergic rhinitis: a prospective observational cohort study[J]. World Allergy Organ J, 2019, 12(4): 100027. PMID: 31193296. PMCID: PMC6526296. DOI: 10.1016/j.waojou.2019.100027.
6 Bro?ek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision[J]. J Allergy Clin Immunol, 2017, 140(4): 950-958. PMID: 28602936. DOI: 10.1016/j.jaci.2017.03.050.
7 Bi J, Hu YQ, Peng ZY, et al. Changes and correlations of serum interleukins, adhesion molecules and soluble E-selectin in children with allergic rhinitis and asthma[J]. Pak J Med Sci, 2018, 34(5): 1288-1292. PMID: 30344593. PMCID: PMC6191801. DOI: 10.12669/pjms.345.15334.
8 Horváth I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease[J]. Eur Respir J, 2017, 49(4): 1600965. PMID: 28446552. DOI: 10.1183/13993003.00965-2016.
9 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016, 54(3): 167-181. PMID: 26957061. DOI: 10.3760/cma.j.issn.0578-1310.2016.03.003.
10 《中华耳鼻咽喉头颈外科杂志》编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组、小儿学组, 《中华儿科杂志》编辑委员会. 儿童变应性鼻炎诊断和治疗的专家共识(2010年, 重庆)[J]. 中华儿科杂志, 2011, 49(2): 116-117. PMID: 21426688. DOI: 10.3760/cma.j.issn.0578-1310.2011.02.009.
11 Wald ER, Applegate KE, Bordley C, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years[J]. Pediatrics, 2013, 132(1): e262-e280. PMID: 23796742. DOI: 10.1542/peds.2013-1071.
12 Voorend-van Bergen S, Vaessen-Verberne AA, de Jongste JC, et al. Asthma control questionnaires in the management of asthma in children: a review[J]. Pediatr Pulmonol, 2015, 50(2): 202-208. PMID: 25187271. DOI: 10.1002/ppul.23098.
13 Tosca MA, Schiavetti I, Ciprandi G, et al. The challenge of asthma control grading in clinical practice[J]. Respir Investig, 2021, 59(5): 683-685. PMID: 34301508. DOI: 10.1016/j.resinv.2021.06.001.
14 Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases[J]. Lancet, 2018, 391(10118): 350-400. PMID: 28911920. DOI: 10.1016/S0140-6736(17)30879-6.
15 Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5): 602-615. PMID: 21885636. PMCID: PMC4408724. DOI: 10.1164/rccm.9120-11ST.
16 Badar A, Salem AM, Bamosa AO, et al. Association between FeNO, total blood IgE, peripheral blood eosinophil and inflammatory cytokines in partly controlled asthma[J]. J Asthma Allergy, 2020, 13: 533-543. PMID: 33149625. PMCID: PMC7605921. DOI: 10.2147/JAA.S274022.
17 Gao J, Wu F. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma[J]. Allergy Asthma Clin Immunol, 2018, 14: 21. PMID: 29796021. PMCID: PMC5964674. DOI: 10.1186/s13223-018-0248-7.
18 Duong-Quy S. Clinical utility of the exhaled nitric oxide (NO) measurement with portable devices in the management of allergic airway inflammation and asthma[J]. J Asthma Allergy, 2019, 12: 331-341. PMID: 31632093. PMCID: PMC6789173. DOI: 10.2147/JAA.S190489.
19 Ren L, Zhang W, Zhang Y, et al. Nasal nitric oxide is correlated with nasal patency and nasal symptoms[J]. Allergy Asthma Immunol Res, 2019, 11(3): 367-380. PMID: 30912326. PMCID: PMC6439193. DOI: 10.4168/aair.2019.11.3.367.
20 Zhang Y, Zhang L. Increasing prevalence of allergic rhinitis in China[J]. Allergy Asthma Immunol Res, 2019, 11(2): 156-169. PMID: 30661309. PMCID: PMC6340797. DOI: 10.4168/aair.2019.11.2.156.
21 You SH, Zhang J, Bai Y, et al. Normal values of nasal NO and exhaled NO in young Chinese people aged 9-22 years[J]. World J Otorhinolaryngol Head Neck Surg, 2016, 2(1): 22-27. PMID: 29204545. PMCID: PMC5698517. DOI: 10.1016/j.wjorl.2016.02.004.
22 Menou A, Babeanu D, Paruit HN, et al. Normal values of offline exhaled and nasal nitric oxide in healthy children and teens using chemiluminescence[J]. J Breath Res, 2017, 11(3): 036008. PMID: 28579561. DOI: 10.1088/1752-7163/aa76ef.
23 Duong-Quy S, Vu-Minh T, Hua-Huy T, et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma[J]. J Asthma Allergy, 2017, 10: 75-82. PMID: 28356764. PMCID: PMC5367560. DOI: 10.2147/JAA.S129047.
24 Chen QB, Chen L, Zheng XY, et al. The clinical significance of nasal nitric oxide concentrations in preschool children with nasal inflammatory disease[J]. Int Arch Allergy Immunol, 2020, 181(1): 51-55. PMID: 31752005. DOI: 10.1159/000504192.
25 Arasi S, Porcaro F, Cutrera R, et al. Severe asthma and allergy: a pediatric perspective[J]. Front Pediatr, 2019, 7: 28. PMID: 30805326. PMCID: PMC6378301. DOI: 10.3389/fped.2019.00028.
26 Togias A, Gergen PJ, Hu JW, et al. Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes[J]. J Allergy Clin Immunol, 2019, 143(3): 1003-1011.e10. PMID: 30213627. PMCID: PMC6408960. DOI: 10.1016/j.jaci.2018.07.041.